These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2105510)

  • 21. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
    Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
    Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials.
    Burke DA; Mitchell KW; al Mardini H; Record CO
    Lancet; 1988 Aug; 2(8609):505-6. PubMed ID: 2900422
    [No Abstract]   [Full Text] [Related]  

  • 24. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B; Kjaergard LL; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
    Goh ET; Andersen ML; Morgan MY; Gluud LL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002798. PubMed ID: 28745801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of benzodiazepine in hepatic encephalopathy.
    Mullen KD
    Hepatology; 1995 Feb; 21(2):604-5. PubMed ID: 7843738
    [No Abstract]   [Full Text] [Related]  

  • 27. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flumazenil for hepatic coma: the elusive wake-up call?
    Sterling RK; Shiffman ML; Schubert ML
    Gastroenterology; 1994 Oct; 107(4):1204-5. PubMed ID: 7926473
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
    Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ro 15-1788 and hepatic failure.
    Sutherland LR; Minuk GY
    Ann Intern Med; 1988 Jan; 108(1):158. PubMed ID: 3122615
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
    Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T
    Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Flumazenil in the Management of Hepatic Encephalopathy.
    Agrawal A; Diez A; Bajaj D
    Am J Ther; 2020; 27(6):e629-e630. PubMed ID: 31241495
    [No Abstract]   [Full Text] [Related]  

  • 39. Benzodiazepine receptors and hepatic encephalopathy.
    Butterworth RF; Pomier Layrargues G
    Hepatology; 1990 Mar; 11(3):499-501. PubMed ID: 2155867
    [No Abstract]   [Full Text] [Related]  

  • 40. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
    Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.